至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Degron capability of the hydrophobic C-terminus of the polyglutamine disease protein, ataxin-3

J Neurosci Res. 2020-07-01; 
Jessica R Blount, Sean L Johnson, Kozeta Libohova, Sokol V Todi, Wei-Ling Tsou
Products/Services Used Details Operation
Mammalian Expression … 2.2 Plasmids, mammalian cells, and transfections. Ataxin‐3 and eGFP variants were synthesized by the company Genscript (genscript.com) and subcloned into HA‐tagged, pCDNA3.1(+1) for ataxin‐3 or pCDNA3.1+N‐eGFP for eGFP … Get A Quote

摘要

Ataxin-3 is a deubiquitinase and polyglutamine disease protein whose cellular properties and functions are not entirely understood. Mutations in ataxin-3 cause spinocerebellar ataxia type 3 (SCA3), a neurodegenerative disorder that is a member of the polyglutamine family of diseases. Two major isoforms arise from alternative splicing of ATXN3 and are differently toxic in vivo as a result of faster proteasomal degradation of one isoform compared to the other. The isoforms vary only at their C-termini, suggesting that the hydrophobic C-terminus of the more quickly degraded form of ataxin-3 (here referred to as isoform 2) functions as a degron-that is, a peptide sequence that expedites the degradation of its host ... More

关键词

RRID:AB_1281300, RRID:AB_2307391, RRID:SCR_001010, ataxia, deubiquitinase, isoform, neurodegeneration, polyglutamine, proteasome, ubiquitin